Literature DB >> 2704583

Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia.

J M Davis1, V K Bhutani, J L Stefano, W W Fox, A R Spitzer.   

Abstract

The effects of caffeine upon pulmonary mechanics were measured in 16 infants with bronchopulmonary dysplasia (BPD). Pulmonary function tests were performed immediately prior to and 1 hour following a dose of 10 mg/kg of caffeine. A 37% increase in minute ventilation (mean +/- SEM; 436.6 +/- 26.3 to 580.8 +/- 30.7 ml/min/kg) was seen with caffeine administration (P less than 0.001), primarily from a 42% increase in tidal volume (6.2 +/- 0.4 to 8.5 +/- 0.4 ml/kg) (P less than 0.001). Total lung resistance decreased by 20% (134.6 + 24.2 to 105.3 +/- 20.1 cmH2O/L/sec) (P = 0.01), and total pulmonary compliance improved by 47% (0.642 +/- 0.104 to 0.908 +/- 0.190 ml/cmH2O/kg) (P less than 0.01). In five matched control infants with BPD, no effects of placebo upon pulmonary mechanics were detected. Since caffeine has a wide therapeutic index with few side effects, it may be an effective adjunct in the treatment of infants with BPD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2704583     DOI: 10.1002/ppul.1950060112

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  10 in total

1.  Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants.

Authors:  Zainab Kassim; Anne Greenough; Gerrard F Rafferty
Journal:  Eur J Pediatr       Date:  2009-03-07       Impact factor: 3.183

Review 2.  The Role of Caffeine in Noninvasive Respiratory Support.

Authors:  Nicole R Dobson; Ravi Mangal Patel
Journal:  Clin Perinatol       Date:  2016-09-28       Impact factor: 3.430

3.  A systematic review and meta-analysis of pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome.

Authors:  Zongyan Yi; Yajuan Tan; Yang Liu; Ling Jiang; Li Luo; Liang Wang; Wei Lei; Jiping Tan; Ruofen Yan
Journal:  Transl Pediatr       Date:  2022-04

4.  Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants.

Authors:  Nicole R Dobson; Ravi M Patel; P Brian Smith; Devon R Kuehn; Jennifer Clark; Shilpa Vyas-Read; Amy Herring; Matthew M Laughon; David Carlton; Carl E Hunt
Journal:  J Pediatr       Date:  2014-01-23       Impact factor: 4.406

5.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 6.  Caffeine therapy in preterm infants.

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  World J Clin Pediatr       Date:  2015-11-08

7.  Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells.

Authors:  Daniel Janitschke; Anna A Lauer; Cornel M Bachmann; Martin Seyfried; Heike S Grimm; Tobias Hartmann; Marcus O W Grimm
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

Review 8.  Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?

Authors:  Rishika P Sakaria; Ramasubbareddy Dhanireddy
Journal:  Front Pediatr       Date:  2022-03-09       Impact factor: 3.418

9.  Early Caffeine Prophylaxis and Risk of Failure of Initial Continuous Positive Airway Pressure in Very Low Birth Weight Infants.

Authors:  Ravi M Patel; Kanecia Zimmerman; David P Carlton; Reese Clark; Daniel K Benjamin; P Brian Smith
Journal:  J Pediatr       Date:  2017-09-07       Impact factor: 6.314

Review 10.  Drug therapy for the prevention and treatment of bronchopulmonary dysplasia.

Authors:  Anjali Iyengar; Jonathan M Davis
Journal:  Front Pharmacol       Date:  2015-02-16       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.